Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Gyurkocza
    Gyurkocza
  3. Papadopoulos
    Papadopoulos
  4. Perales
    Perales
  5. Jakubowski
    Jakubowski
  6. Tamari
    Tamari
  7. Devlin
    Devlin
  8. Shah
    Shah
  9. Castro-Malaspina
    Castro-Malaspina
  10. Ponce
    Ponce

Groups

  1. Bone Marrow Transplant (26)
  2. Center for Hematologic Malignancies (26)
  3. Department of Medicine (26)
  4. Hematologic Malignancies, Division of (26)
  5. Survivorship Research (26)
  6. CTCR Scholars (24)
  7. MSK Grad Students (24)
  8. Master of Science in Clinical and Translational Cancer Research (24)
  9. Biostatistics Service (20)
  10. DigITs Research Group (20)
Search Within
  1. "Miguel-Angel Perales"
  2. "Esperanza Papadopoulos"
  3. "Boglarka Gyurkocza"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (9)
Groups
  1. Bone Marrow Transplant (26)
  2. Center for Hematologic Malignancies (26)
  3. Department of Medicine (26)
  4. Hematologic Malignancies, Division of (26)
  5. Survivorship Research (26)
  6. CTCR Scholars (24)

More Groups

People
  1. Boglarka Gyurkocza (26)
  2. Esperanza Papadopoulos (26)
  3. Miguel-Angel Perales (26)
  4. Sergio Giralt (26)
  5. Ann Jakubowski (24)
  6. Brian Shaffer (22)

More People

Years
  1. 2024 (1)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (4)
  5. 2019 (5)
  6. 2018 (7)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (20)
  2. Transplantation and Cellular Therapy (6)

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Racial disparities in access to alternative donor allografts persist in the era of “Donors for all”
    Meeting Abstract

    Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Quach, S.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase inhibitor era
    Meeting Abstract

    Vaughn, J. L.; Devlin, S. M.; Berman, E.; Mauro, M. J.; Papadopoulos, E. B.; Perales, M. A.; Tallman, M.; Giralt, S. A.; Gyurkocza, B.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Fractionated infusion of hematopoietic progenitor cells does not improve neutrophil recovery or survival in allograft recipients
    Journal Article

    Tamari, R.; Brown, S.; Devlin, S. M.; Kosuri, S.; Maloy, M. A.; Ponce, D. M.; Sauter, C.; Shaffer, B.; Dahi, P.; Young, J. W.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy
    Journal Article

    Zuanelli Brambilla, C.; Lobaugh, S. M.; Ruiz, J. D.; Dahi, P. B.; Goldberg, A. D.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves
    Journal Article

    Nawas, M. T.; Shah, G. L.; Feldman, D. R.; Ruiz, J. D.; Robilotti, E. V.; Aslam, A. A.; Dundas, M.; Kamboj, M.; Barker, J. N.; Cho, C.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Long-term survival in patients with AML or MDS relapsed after allogeneic hematopoietic cell transplantation: Importance of second cell therapy
    Meeting Abstract

    Zuanelli Brambilla, C.; Ruiz, J. D.; Lobaugh, S. M.; Dahi, P. B.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; Sanchez Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT)
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Skinner, K.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save